Clinical Trials Directory

Trials / Conditions / AML, Childhood

AML, Childhood

9 registered clinical trials studyying AML, Childhood — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingCAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
NCT06326463
St. Jude Children's Research HospitalPhase 1
WithdrawnELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML
NCT05622591
Elucida OncologyPhase 1
RecruitingPilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant
NCT06158828
Washington University School of MedicinePhase 1 / Phase 2
RecruitingSafety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
NCT06316960
Children's Hospital of Soochow UniversityPhase 2
RecruitingClinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents W
NCT06221683
Children's Hospital of Soochow UniversityPhase 2
CompletedRetun-to-school Adaptation Program for Children With Cancer
NCT06389357
Gazi UniversityN/A
TerminatedA Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT05077423
Y-mAbs TherapeuticsPhase 1
TerminatedAflacLL1901 (CHOA-AML)
NCT04326439
Emory UniversityPhase 2
UnknownNivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
NCT03825367
Therapeutic Advances in Childhood Leukemia ConsortiumPhase 1 / Phase 2